Research approaches for studying flow-induced thromboembolic complications in blood recirculating devices

Expert Review of Medical Devices

Volumn 1, Issue 1, 2004, Pages 65-80

  Bluestein, Danny ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Blood flow; Cardiovascular devices; MES; Platelets; Prosthetic heart valves; Thromboembolism; VAD

Indexed keywords

ANTICOAGULANT AGENT; CARDIOVASCULAR AGENT;

ARTIFICIAL HEART; BIOMEDICAL TECHNOLOGY ASSESSMENT; BJOERK SHILEY VALVE PROSTHESIS; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DISEASE MODEL; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; HEALTH CARE COST; HEART ASSIST DEVICE; HEART GRAFT; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; REVIEW; RISK ASSESSMENT; SAINT JUDE HEART VALVE PROSTHESIS; STROKE; THROMBOCYTE DISORDER; THROMBOEMBOLISM; THROMBOGENICITY; VALVULAR HEART DISEASE;

EID: 12344315538     PISSN: 17434440     EISSN: None     Source Type: Journal    
DOI: 10.1586/17434440.1.1.65     Document Type: Review

References (139)

1. Rose EA, Moskowitz AJ et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann. Thorac. Surg. 67(3), 723-730 (1999).
2. Butchart EG, Ionescu A et al. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 108(Suppl. 1), 68-74 (2003).
3. Butchart EG, Lewis PA. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation. Experience with 1004 Medtronic Hall valves. Circulation 78(3), 66-77 (1988).
4. Butchart EG, Lewis PA et al. Anticoagulation variability between centers: implications for comparative prosthetic valve assessment. Eur. J. Cardiothorac. Surg. 2(2), 72-81 (1988).
5. Butchart EG, Li HH et al. Twenty years' experience with the Medtronic Hall valve. J. Thorac. Cardiovasc. Surg. 121(6), 1090-1100 (2001).
6. Pumphrey CW, Dawes J. Platelet α granule depletion: findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery. Thromb. Res. 30(3), 257-264 (1983).
7. Edmunds LH Jr. Is prosthetic valve thrombogenicity related to design or material? Tex. Heart Inst. J. 23(1), 24-27 (1996).
8. Edmunds LH Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann. Thorac. Surg. 44(4), 430-445 (1987).
9. Edmunds LH Jr, McKinlay S et al. Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. J. Biomed Mater. Res. 38(3), 263-266 (1997).
10. Rams JJ, Davis DA et al. Detection of microemboli in patients with artificial heart valves using transcranial Doppler: preliminary observations. J. Heart Valve Dis. 2(1), 37-41 (1993).
11. Grosset DG, Georgiadis D et al. Detection of microemboli by transcranial Doppler ultrasound. Tex. Heart Inst. J. 23(4), 289-292 (1996).
12. Georgiadis D, Kaps M et al. Transcranial Doppler detection of microemboli in prosthetic heart valve patients: dependency upon valve type. Eur. J. Cardiothorac. Surg. 10(4), 253-258 (1996 ).
13. Notzold A, Droste W et al. Circulating microemboli in patients after aortic valve replacement with pulmonary autografts and mechanical valve prostheses. Circulation 96(6), 1843-1846 (1997).
14. Kleine P, Perthel M et al. Downstream turbulence and high intensity transient signals (HITS) following aortic valve replacement with Medtronic Hall or St. Jude Medical valve substitutes. Eur. J. Cardiothorac. Surg. 17(1), 20-24 (2000).
15. Wilhelm CR, Ristich J et al. Measurement of hemostatic indexes in conjunction with transcranial doppler sonography in patients with ventricular assist devices. Stroke 30(12), 2554-2561 (1999).
16. Herrmann M, Ebert AD et al. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke 31(3), 645-450 (2000).
17. Kroll MH, Hellums JD et al. Platelets and shear stress. Blood 88(5), 1525-1541 (1996).
18. Grigioni M, Daniele C et al. The power-law mathematical model for blood damage prediction: analytical developments and physical inconsistencies. Artif. Organs 28(5), 467-475 (2004).
19. Tuszynski GP, Rothman VL et al. Thrombospondin promotes platelet aggregation. Blood 72(1), 109-115 (1988).
20. Merten M, Chow T et al. A new role for P-selectin in shear-induced platelet aggregation. Circulation 102(17), 2045-2050 (2000).
21. Janes SL, Wilson DJ et al. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb. Hemost. 70(4), 659-666 (1993).
22. Bevers EM, Comfurius P, Zwaal RF. Mechanisms involved in platelet procoagulant response. Adv. Exp. Med. Biol. 344, 195-207 (1993).
23. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J. Biol. Chem. 260(4), 2119-2124 (1985).
24. Nesheim ME, Nichols WL et al. Isolation and study of an acquired inhibitor of human coagulation Factor V. J. Clin. Invest. 77(2), 405-415 (1986).
25. Hellums JR, Frensley WR. Non-Markovian open-system boundary conditions for the time-dependent Schrodinger equation. Physical Rev. B. Condensed Matter 49(4), 2904-2906 (1994).
26. O'Brien JR. Shear-induced platelet aggregation. Lancet 335(8691), 711-713 (1990).
27. O'Brien JR, Salmon GP. An independent hemostatic mechanism: shear-induced platelet aggregation. Adv. Exp. Med. Biol. 281, 287-296 (1990).
28. Folie BJ, McIntire LV. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys. J. 56(6), 1121-1141 (1989 ).
29. Alveriadou B, Moake J et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81, 1263-1276 (1993 ).
30. Slack S. Fluid dynamic and hemorheologic considerations. Cardiovasc. Pathol. 2(Suppl. 3), S11-S21 (1993).
31. Strony J, Beaudoin A et al. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am. J. Physiol. 265(5), H1787-H1796 (1993).
32. Hellums J, Peterson D et al. Studies on the mechanisms of shear-induced platelet activation. In: Cerebral Ischaemia and Hemorhelogy. Hartman A, Kuschinsky W (Eds). Springer and Verlag, NY, USA, 80-89 (1987).
33. Sutera SP, Nowak MD et al. A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions. Biorheology 25(3), 449-459 (1988).
34. Purvis, NB Jr, Giorgio TD. The effects of elongational stress exposure on the activation and aggregation of blood platelets. Biorheology 28(5), 355-367 (1991).
35. Cao J, Rittgers SE. Particle motion within in vitro models of stenosed internal carotid and left anterior descending coronary arteries. Ann. Biomed. Eng. 26(2), 190-199 (1998).
36. Bluestein D, Li YM, Krukenkamp IB. Free emboli formation in the wake of bileaflet mechanical heart valves and the effects of implantation techniques. J. Biomech. 35(12), 1533-1540 (2002).
37. Bluestein D, Niu L et al. Fluid mechanics of arterial stenosis: relationship to the development of mural thrombus. Ann. Biomed. Eng. 25(2), 344-356 (1997).
38. Bluestein D, Rambod E, Gharib M. Vortex shedding as a mechanism for free emboli formation in mechanical heart valves. J. Biomech. Eng. 122(2), 125-134 (2000).
39. Paul R, Marseille O et al. In vitro thrombogenicity testing of artificial organs. Int. J. Artif. Organs 21(9), 548-52 (1998).
40. Schima H, Muller MR. Minimization of hemolysis in centrifugal blood pumps: influence of different geometries. Int. J. Artif. Organs 16(7), 521-529 (1993).
41. Schima H, Siegel H et al. In vitro investigation of thrombogenesis in rotary blood pumps. Artif. Organs 17(7), 605-608 (1993).
42. Jesty J, Bluestein D. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin. Anal. Biochem. 272(1), 64-70 (1999).
43. Kawahito K, Adachi H, Ino T. Platelet activation in the gyro C1E3 centrifugal pump: comparison with the terumo capiox and the Nikkiso HPM-15. Artif. Organs 24(11), 889-892 (2000).
44. Travis BR, Leo HL et al. An analysis of turbulent shear stresses in leakage flow through a bileaflet mechanical prostheses. J. Biomech. Eng. 124(2), 155-165 (2002).
45. Travis BR, Marzec UM et al. The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulus. J. Heart Valve Dis. 10(2), 228-238 (2001).
46. Travis BR, Marzec UM et al. Bileaflet aortic valve prosthesis pivot geometry influences platelet secretion and anionic phospholipid exposure. Ann. Biomed. Eng. 29(8), 657-664 (2001).
47. Jesty J, Yin W et al. Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time. Platelets 14(3), 143-149 (2003).
48. Charron M, Follansbee W et al. Assessment of biventricular cardiac function in patients with a Novacor left ventricular assist device. J. Heart Lung Transplant 13(2), 263-267 (1994).
49. Gruber EM, Seitelberger R et al. Ventricular thrombus and subarachnoid bleeding during support with ventricular assist devices. Ann. Thorac. Surg. 67(6), 1778-1780 (1999).
50. Sabbah HN, Stein PD. Fluid dynamic stresses in the region of a porcine bioprosthetic valve. Henry Ford Hosp. Med. J. 30(3), 134-138 (1982).
51. Stein PD, Sabbah HN et al. Frequency content of heart sounds and systolic murmurs in patients with porcine bioprosthetic valves: diagnostic value for the early detection of valvular degeneration. Henry Ford Hosp. Med. J. 30(3), 119-123 (1982).
52. Stein PD, Walburn FJ, Sabbah HN. Turbulent stresses in the region of aortic and pulmonary valves. J. Biomech. Eng. 104(3), 238-244 (1982).
53. Yoganathan AP, Woo YR, Sung HW. Turbulent shear stress measurements in the vicinity of aortic heart valve prostheses. J. Biomech. 19(6), 433-442 (1986).
54. Bluestein D, Einav S, Hwang NH. A squeeze flow phenomenon at the closing of a bileaflet mechanical heart valve prosthesis. J. Biomech. 27(11), 1369-1378 (1994).
55. Bodnar E. The Medtronic Parallel valve and the lessons learned. J. Heart Valve Dis. 5(6), 572-573 (1996).
56. Yoganathan AP, Ellis JT et al. Fluid dynamic studies for the year 2000. J. Heart Valve Dis. 7(2), 130-139 (1998).
57. Healy TM, Ellis JT et al. An automated method for analysis and visualization of laser Doppler velocimetry data. Ann. Biomed. Eng. 25(2), 335-343 (1997).
58. McCarthy PM, Nakatani S et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann. Thorac. Surg. 59(3), 609-613 (1995).
59. Vetter HO, Kaulbach HG et al. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system. J. Thorac. Cardiovasc. Surg. 109(1), 74-80 (1995).
60. Kasirajan V, McCarthy PM et al. Clinical experience with long-term use of implantable left ventricular assist devices: indications, implantation, and outcomes. Semin. Thorac. Cardiovasc. Surg. 12(3), 229-237 (2000).
61. Korn RL, Fisher CA et al. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 111(5), 1073-1084 (1996).
62. Rothenburger M, Willhelm MJ et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 106(12 Suppl. 1), 189-192 (2002).
63. Wilhelm MJ, Hammel D et al. Clinical experience with nine patients supported by the continuous flow Debakey VAD. J. Heart Lung Transplant 20(2), 201 (2001).
64. Jin W, Clark C. Experimental investigation of unsteady flow behaviour within a sac-type ventricular assist device (VAD). J. Biomech. 26(6), 697-707 (1993).
65. Bluestein D, Yin W, Affeld K, Jesty J. Flow-induced platelet activation in a mechanical heart valve. J. Heart Valve Dis. 13(3), 501-508 (2004).
66. Yin W, Yared A, Jesty J, Affeld K, Bluestein D. Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valves in a left ventricular assist device. Ann. Biomed. Engr. 32(8), 1058-1066 (2004).
67. DeWall RA, Ellis RL. Implantation techniques: a primary consideration in valve surgery. Ann. Thorac. Surg. 48(Suppl. 3), S59-S60 (1989).
68. Antunes MJ, Colsen PR, Kinsley RH. Intermittent aortic regurgitation following aortic valve replacement with the Hall-Kaster prosthesis. J. Thorac. Cardiovasc. Surg. 84(5), 751-754 (1982).
69. Omoto R, Matsumura M et al. Doppler ultrasound examination of prosthetic function and ventricular blood flow after mitral valve replacement. Herz 11(6), 346-350 (1986).
70. Bjork VO. Optimal orientation of the 60 degrees and the 70 degrees Bjork-Shiley tilting disc valves. Scand. J. Thorac. Cardiovasc. Surg. 16(2), 113-118 (1982).
71. Hall KV. Surgical considerations for avoiding disc interference based on a ten-year experience with the Medtronic Hall heart valve. J. Card. Surg. 3(2), 103-108 (1988).
72. Antunes MJ. Technique of implantation of the Medtronic-Hall valve and other modern tilting-disc prostheses. J. Card. Surg. 5(2), 86-92 (1990).
73. Chandran KB, Khalighi B et al. Effect of valve orientation on flow development past aortic valve prostheses in a model human aorta. J. Thorac. Cardiovasc. Surg. 85(6), 893-901 (1983).
74. Chandran KB, Schoephoerster R, Dellsperger KC. Effect of prosthetic mitral valve geometry and orientation on flow dynamics in a model human left ventricle. J. Biomech. 22(1), 51-65 (1989).
75. Laas J, Kleine P et al. Orientation of tilting disc and bileaflet aortic valve substitutes for optimal hemodynamics. Ann. Thorac. Surg. 68(3), 1096-1099 (1999).
76. Mackay TG, Georgiadis D et al. On the origin of cerebrovascular microemboli associated with prosthetic heart valves. Neurol. Res. 17(5), 349-352 (1995).
77. Braekken SK, Reinvand I et al. Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J. Neurol. Neurosurg. Psychiatry 65(4), 573-576 (1998).
78. Russell D, Madden KP et al. Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke 22(2), 253-258 (1991).
79. Markus H, Loh A, Brown MM. Detection of circulating cerebral emboli using Doppler ultrasound in a sheep model. J. Neurol. Sci. 122(1), 117-124 (1994).
80. Georgiadis D, Mackay TG et al. Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke 25(8), 1559-1563 (1994).
81. Dewanjee MK, Zhai P et al. A new method for quantitation of platelet microthrombi and microemboli from cardiopulmonary bypass in organs using 111In labeled platelets. ASAIO J. 43(5), M701-M705 (1997).
82. Droste DW, Hagedorn G et al. Bigated transcranial Doppler for the detection of clinically silent circulating emboli in normal persons and patients with prosthetic cardiac valves. Stroke 28(3), 588-592 (1997).
83. Droste DW, Hansberg T et al. Oxygen inhalation can differentiate gaseous from nongaseous microemboli detected by transcranial Doppler ultrasound. Stroke 28(12), 2453-2456 (1997).
84. Conger JL, Deklunder GM et al. A bovine model for detecting high intensity transient signals originating from mechanical heart valves. ASAIO J. 46(3), 344-350 (2000).
85. Georgiadis D, Baumgartner RW et al. Venous microemboli in patients with artificial heart valves. Cerebrovasc. Dis. 9(4), 238-241 (1999).
86. Devuyst G, Vesin JM et al. The matching pursuit: a new method of characterizing microembolic signals? Ultrasound Med. Biol. 26(6), 1051-1056 (2000).
87. van Gestel MA, Heemskerk JW et al. Real-time detection of activation patterns in individual platelets during thromboembolism in vivo: differences between thrombus growth and embolus formation. J. Vasc. Res. 39(6), 534-543 (2002).
88. Laas J, Kseibi S et al. Impact of high intensity transient signals on the choice of mechanical aortic valve substitutes. Eur. J. Cardiothorac. Surg. 23(1), 93-96 (2003).
89. Schima H, Wieselthaler G. Mechanically-induced blood trauma: are the relevant questions already solved, or is it still an important field to be investigated? Artif. Organs 19(7), 563-564 (1995).
90. Yeh C, Calvez AC, Eckstein EC. An estimated shape function for drift in a platelet-transport model. Biophys. J. 67(3), 1252-1259 (1994).
91. Yeh C, Eckstein EC. Transient lateral transport of platelet-sized particles in flowing blood suspensions. Biophys. J. 66(5), 1706-1716 (1994).
92. Brown CH 3rd, Lemuth RF et al. Response of human platelets to sheer stress. Trans. Am. Soc. Artif. Intern. Organs 21, 35-39 (1975).
93. Brown CH 3rd, Leverett LB et al. Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J. Lab. Clin. Med. 86(3), 462-471 (1975).
94. Sutera SP, Croce PA, Mehrjardi M. Hemolysis and subhemolytic alterations of human RBC induced by turbulent shear flow. Trans. Am. Soc. Artif. Intern. Organs 18, 335-347 (1972).
95. Sutera SP, Mehrjardi MH. Deformation and fragmentation of human red blood cells in turbulent shear flow. Biophys. J. 15(1), 1-10 (1975).
96. Hung TC, Hochmuth RM et al. Shear-induced aggregation and lysis of platelets. Trans. Am. Soc. Artif. Intern. Organs 22, 285-291 (1976).
97. Ramstack JM, Zuckerman L, Mockros LF. Shear-induced activation of platelets. J. Biomech. 12(2), 113-125 (1979).
98. Liu JS, Lu PC, Chu SH. Turbulence characteristics downstream of bileaflet aortic valve prostheses. J. Biomech. Eng. 122(2), 118-124 (2000).
99. Klaus S, Korfer S et al. In vitro blood damage by high shear flow: human versus porcine blood. Int. J. Artif. Organs 25(4), 306-312 (2002).
100. Jones SA. A relationship between Reynolds stresses and viscous dissipation: implications to red cell damage. Ann. Biomed. Eng. 23(1), 21-28 (1995).
101. Lamson TC, Rosenberg G et al. Relative blood damage in the three phases of a prosthetic heart valve flow cycle. ASAIO J. 39(3), M626-M633 (1993).
102. Dowling RD, Etoch SW et al. Current status of the AbioCor implantable replacement heart. Ann. Thorac. Surg. 71(Suppl. 3), S147-S149, S183-S184 (2001).
103. Dowling RD, Gray LA et al. Initial experience with the AbioCor implantable replacement heart system. J. Thorac. Cardiovasc. Surg. 127(1), 131-141 (2004).
104. Dowling RD, Gray LA et al. The AbioCor implantable replacement heart. Ann. Thorac. Surg. 75(Suppl 6), S93-S99 (2003).
105. Hoerner S. Fluid dynamic drag. Hoerner Fluid Dynamics, NJ, USA (1958).
106. Gross JM, Shermer CD, Hwang NH. Vortex shedding in bileaflet heart valve prostheses. ASAIO Trans. 34(3), 845-850 (1988).
107. Reif TH, Schulte TJ, Hwang NH. Estimation of the rotational undamped natural frequency of bileaflet cardiac valve prostheses. J. Biomech. Eng. 112(3), 327-332 (1990).
108. Bluestein D, Einav S. The effect of varying degrees of stenosis on the characteristics of turbulent pulsatile flow through heart valves. J. Biomech. 28(8), 915-924 (1995).
109. Bluestein D, Einav S, Leondes CT. Techniques in the analysis of stability of pulsatile flow through heart valves. In: Biomechanics Systems Techniques and Applications: Cardiovascular Techniques. Volume 2 CRC Press LLC, FL, USA. 4-1, 4-39 (2001).
110. Bluestein D, Gutierrez C et al. Vortex shedding in steady flow through a model of an arterial stenosis and its relevance to mural platelet deposition. Ann. Biomed. Eng. 27(6), 763-773 (1999 ).
111. Grigioni M, Daniele C et al. The influence of the leaflets' curvature on the flow field in two bileaflet prosthetic heart valves. J. Biomech. 34(5), 613-621 (2001).
112. Wurzinger LJ, Blasberg P, Schmid-Schonbein H. Towards a concept of thrombosis in accelerated flow: rheology, fluid dynamics, and biochemistry. Biorheology 22(5), 437-450 (1985).
113. McQueen DM, Peskin CS. Computer-assisted design of butterfly bileaflet valves for the mitral position. Scand. J. Thorac. Cardiovasc. Surg. 19(2), 139-148 (1985).
114. McQueen DM, Peskin CS. Computer-assisted design of pivoting disc prosthetic mitral valves. J. Thorac. Cardiovasc. Surg. 86(1), 126-135 (1983).
115. McQueen DM, Peskin CS, Yellin EL. Fluid dynamics of the mitral valve: physiological aspects of a mathematical model. Am. J. Physiol. 242(6), H1095-H1110 (1982).
116. Peskin CS, McQueen DM. Cardiac fluid dynamics. Crit. Rev. Biomed. Eng. 20(5-6), 451-459 (1992).
117. Peskin CS, McQueen DM. A general method for the computer simulation of biological systems interacting with fluids. Symp. Soc. Exp. Biol. 49, 265-276 (1995).
118. Huang ZJ, Merkle CL et al. Numerical simulation of unsteady laminar flow through a tilting disk heart valve: prediction of vortex shedding. J. Biomech. 27(4), 391-402 (1994).
119. King MJ, David T, Fisher J. Three-dimensional study of the effect of two leaflet opening angles on the time-dependent flow through a bileaflet mechanical heart valve. Med. Eng. Phys. 19(3), 235-241 (1997).
120. Krafczyk M, Cerrolaza M et al. Analysis of 3D transient blood flow passing through an artificial aortic valve by Lattice-Boltzmann methods. J. Biomech. 31(5), 453-462 (1998).
121. Kelly SG, Verdonck PR et al. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int. J. Artif. Organs 22(11), 754-763 (1999).
122. Kiris C, Kwak D et al. Computational approach for probing the flow through artificial heart devices. J. Biomech. Eng. 119(4), 452-460 (1997).
123. Yeleswarapu KK, Antaki JF et al. A mathematical model for shear-induced hemolysis. Artif. Organs 19(7), 576-582 (1995).
124. Bludszuweit C. Three-dimensional numerical prediction of stress loading of blood particles in a centrifugal pump. Artif. Organs 19(7), 590-596 (1995).
125. Bludszuweit C. Model for a general mechanical blood damage prediction. Artif. Organs 19(7), 583-589 (1995).
126. Apel J, Neudel F, Reul H. Computational fluid dynamics and experimental validation of a microaxial blood pump. ASAIO J. 47(5 , 552-558 (2001).
127. Apel J, Paul R et al. Assessment of hemolysis related quantities in a microaxial blood pump by computational fluid dynamics. Artif. Organs 25(5), 341-347 (2001).
128. Burgreen GW, Antaki JF, Griffith BP. A design improvement strategy for axial blood pumps using computational fluid dynamics. ASAIO J. 42(5), M354-M360 (1996).
129. Burgreen GW, Antaki J et al. Computational fluid dynamics as a development tool for rotary blood pumps. Artif. Organs 25(5), 336-340 (2001).
130. Fogelson AL, Wang NT. Platelet dense-granule centralization and the persistence of ADP secretion. Am. J. Physiol. 270(3), H1131-H1140 (1996).
131. Kuharsky AL, Fogelson AL. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys. J. 80(3), 1050-1074 (2001).
132. Sorensen EN, Burgreen GW et al. Computational simulation of platelet deposition and activation: I. Model development and properties. Ann. Biomed. Eng. 27(4), 436-448 (1999).
133. Sorensen EN, Burgreen GW et al. Computational simulation of platelet deposition and activation: II. Results for Poiseuille flow over collagen. Ann. Biomed. Eng. 27(4), 449-458 (1999).
134. Wilcox DC. Simulation of transition with a two-equation turbulence model. AIAA J. 32(2), 247-255 (1994).
135. Paulsen PK, Hasenkam JM et al. Three-dimensional visualization of velocity profiles in the ascending aorta in humans. A comparative study among normal aortic valves, St. Jude Medical and Starr-Edwards Silastic Ball valves. Int. J. Artif. Organs 11(4), 277-292 (1988).
136. Gosman A, Ioannides L. Aspects of compuer simulation of liquid-fueled cumbustors. AIAA 19th Aerospace Science Meeting. NV, USA 81-0323 (1981).
137. Gosman AD. Aspects of computer simulation of liquid-fuelled combustors. AIAA J. Energy 7(6), 482-490 (1983).
138. Hinze JO. Turbulence. McGraw-Hill, NY, USA, 493, 22-23 (1987),
139. Jesty J, Nemerson Y. In: Williams Hematology. Fifth Edition. Beutler E, Lichtman MA, Coller BS, Kipps TJ (Eds). McGraw-Hill, NY, USA, 1227-1238 (1995).